Correlation Between Chase Growth and Biotechnology Fund

Can any of the company-specific risk be diversified away by investing in both Chase Growth and Biotechnology Fund at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chase Growth and Biotechnology Fund into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chase Growth Fund and Biotechnology Fund Class, you can compare the effects of market volatilities on Chase Growth and Biotechnology Fund and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chase Growth with a short position of Biotechnology Fund. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chase Growth and Biotechnology Fund.

Diversification Opportunities for Chase Growth and Biotechnology Fund

0.51

Correlation Coefficient

Chase Growth  Biotechnology Fund

Very weak diversification

The 3 months correlation between Chase and Biotechnology is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Chase Growth Fund and Biotechnology Fund Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Fund Class and Chase Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chase Growth Fund are associated (or correlated) with Biotechnology Fund. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Fund Class has no effect on the direction of Chase Growth i.e., Chase Growth and Biotechnology Fund go up and down completely randomly.

Pair Corralation between Chase Growth and Biotechnology Fund

Assuming the 90 days horizon Chase Growth Fund is expected to generate 0.92 times more return on investment than Biotechnology Fund. However, Chase Growth Fund is 1.09 times less risky than Biotechnology Fund. It trades about 0.05 of its potential returns per unit of risk. Biotechnology Fund Class is currently generating about 0.0 per unit of risk. If you would invest  1,056  in Chase Growth Fund on December 2, 2024 and sell it today you would earn a total of  363.00  from holding Chase Growth Fund or generate 34.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Chase Growth Fund  vs.  Biotechnology Fund Class

Chase Growth

Risk-Adjusted Performance

Very Weak

Over the last 90 days Chase Growth Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Biotechnology Fund Class

Risk-Adjusted Performance

Very Weak

Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's technical and fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Pair Trading with Chase Growth and Biotechnology Fund

The main advantage of trading using opposite Chase Growth and Biotechnology Fund positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chase Growth position performs unexpectedly, Biotechnology Fund can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Fund will offset losses from the drop in Biotechnology Fund's long position.

The idea behind Chase Growth Fund and Biotechnology Fund Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.